Evidence map›Paper›PMID 33389502›Full record

ArticleInternational urology and nephrology2021

A rare case report of reversible acute kidney injury due to hyperuricemia alone.

Yan Zhang, Wei-Xiu Wang, Xiao-Xiao Zhang, Man-Yu Zhang, Ya-Ru Ren, Ding-Wei Yang

Open access · hybridAbstract readCase ReportsLetter
In one paragraph

Article in International urology and nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yan ZhangDivision of Nephrology, Department of Internal Medicine, Tianjin Hospital, No. 406 Jiefang South Road, Hexi, Tianjin, 300211, China.
Wei-Xiu WangDivision of Nephrology, Department of Internal Medicine, Tianjin Hospital, No. 406 Jiefang South Road, Hexi, Tianjin, 300211, China.
Xiao-Xiao ZhangDivision of Nephrology, Department of Internal Medicine, Tianjin Hospital, No. 406 Jiefang South Road, Hexi, Tianjin, 300211, China.
Man-Yu ZhangDivision of Nephrology, Department of Internal Medicine, Tianjin Hospital, No. 406 Jiefang South Road, Hexi, Tianjin, 300211, China.
Ya-Ru RenGraduate School, Tianjin Medical University, Tianjin, China.
Ding-Wei YangDivision of Nephrology, Department of Internal Medicine, Tianjin Hospital, No. 406 Jiefang South Road, Hexi, Tianjin, 300211, China. dwyang2016@126.com.ORCID http://orcid.org/0000-0002-7888-6126
Tianjin Hospital · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Kidney InjuryAdultBiomarkersCombined Modality TherapyDrug Therapy, CombinationHumansHyperuricemiaMaleRenal DialysisBiomarkers

Identifiers

PMID33389502
PMCPMC8463400
OpenAlexW3119649414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.